Nova Cannabis Inc
OTC:NVACF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nova Cannabis Inc
OTC:NVACF
|
CA |
|
QBE Insurance Group Ltd
ASX:QBE
|
AU |
|
Spire Global Inc
F:43J
|
US |
|
Chimera Investment Corp
NYSE:CIM
|
US |
|
G
|
Gruppo MutuiOnline SpA
MIL:MOL
|
IT |
|
Immutep Ltd
ASX:IMM
|
AU |
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
CA |
|
Shanghai Pudong Development Bank Co Ltd
SSE:600000
|
CN |
|
Lonza Group AG
SIX:LONN
|
CH |
|
T
|
Teledyne Technologies Inc
F:TYZ
|
US |
|
C
|
China Youzan Ltd
OTC:CHNVF
|
HK |
|
Easterly Government Properties Inc
NYSE:DEA
|
US |
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
A
|
Archer Aviation Inc
NYSE:ACHR
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVACF's stock price target?
Not Available
NVACF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nova Cannabis Inc?
Projected CAGR
15%
The compound annual growth rate for Revenue over the next 3 years is 15%.
What is the Gross Profit forecast for Nova Cannabis Inc?
Projected CAGR
-29%
The compound annual growth rate for Gross Profit over the next 1 year is -29%.
What is the Operating Income forecast for Nova Cannabis Inc?
Projected CAGR
47%
The compound annual growth rate for Operating Income over the next 2 years is 47%.